252 related articles for article (PubMed ID: 31206358)
21. Elevated plasma-free cortisol concentrations and ratios are associated with increased mortality even in the presence of statin therapy in patients with severe sepsis.
Venkatesh B; Imeson L; Kruger P; Cohen J; Jones M; Bellomo R; ;
Crit Care Med; 2015 Mar; 43(3):630-5. PubMed ID: 25513788
[TBL] [Abstract][Full Text] [Related]
22. Aetiology, outcomes & predictors of mortality in acute respiratory distress syndrome from a tertiary care centre in north India.
Sharma SK; Gupta A; Biswas A; Sharma A; Malhotra A; Prasad KT; Vishnubhatla S; Ajmani S; Mishra H; Soneja M; Broor S
Indian J Med Res; 2016 Jun; 143(6):782-792. PubMed ID: 27748303
[TBL] [Abstract][Full Text] [Related]
23. Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis.
Palakshappa JA; Anderson BJ; Reilly JP; Shashaty MG; Ueno R; Wu Q; Ittner CA; Tommasini A; Dunn TG; Charles D; Kazi A; Christie JD; Meyer NJ
Crit Care; 2016 Mar; 20():71. PubMed ID: 26984771
[TBL] [Abstract][Full Text] [Related]
24. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.
Dinglas VD; Hopkins RO; Wozniak AW; Hough CL; Morris PE; Jackson JC; Mendez-Tellez PA; Bienvenu OJ; Ely EW; Colantuoni E; Needham DM
Thorax; 2016 May; 71(5):401-10. PubMed ID: 26936876
[TBL] [Abstract][Full Text] [Related]
25. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
Kruger P; Bailey M; Bellomo R; Cooper DJ; Harward M; Higgins A; Howe B; Jones D; Joyce C; Kostner K; McNeil J; Nichol A; Roberts MS; Syres G; Venkatesh B;
Am J Respir Crit Care Med; 2013 Apr; 187(7):743-50. PubMed ID: 23348980
[TBL] [Abstract][Full Text] [Related]
26. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
Needham CJ; Brindley PG
Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
[TBL] [Abstract][Full Text] [Related]
27. Development of a biomarker mortality risk model in acute respiratory distress syndrome.
Bime C; Casanova N; Oita RC; Ndukum J; Lynn H; Camp SM; Lussier Y; Abraham I; Carter D; Miller EJ; Mekontso-Dessap A; Downs CA; Garcia JGN
Crit Care; 2019 Dec; 23(1):410. PubMed ID: 31842964
[TBL] [Abstract][Full Text] [Related]
28. Plasma Nucleosomes Are Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome.
Yehya N; Fazelinia H; Lawrence GG; Spruce LA; Mai MV; Worthen GS; Christie JD
Crit Care Med; 2021 Jul; 49(7):1149-1158. PubMed ID: 33729723
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of statin therapy in patients with acute respiratory distress syndrome/acute lung injury: a systematic review and meta-analysis.
Feng Y
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3190-3198. PubMed ID: 29863265
[TBL] [Abstract][Full Text] [Related]
30. A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome.
Vincent JL; Artigas A; Petersen LC; Meyer C
Crit Care Med; 2009 Jun; 37(6):1874-80. PubMed ID: 19384216
[TBL] [Abstract][Full Text] [Related]
31. The 67gallium-transferrin pulmonary leak index in patients at risk for the acute respiratory distress syndrome.
Groeneveld AB; Raijmakers PG
Crit Care Med; 1998 Apr; 26(4):685-91. PubMed ID: 9559605
[TBL] [Abstract][Full Text] [Related]
32. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.
Schuster DP; Metzler M; Opal S; Lowry S; Balk R; Abraham E; Levy H; Slotman G; Coyne E; Souza S; Pribble J;
Crit Care Med; 2003 Jun; 31(6):1612-9. PubMed ID: 12794395
[TBL] [Abstract][Full Text] [Related]
33. Statins and delirium during critical illness: a multicenter, prospective cohort study.
Morandi A; Hughes CG; Thompson JL; Pandharipande PP; Shintani AK; Vasilevskis EE; Han JH; Jackson JC; Laskowitz DT; Bernard GR; Ely EW; Girard TD
Crit Care Med; 2014 Aug; 42(8):1899-909. PubMed ID: 24810528
[TBL] [Abstract][Full Text] [Related]
34. Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial.
Gaudry S; Hajage D; Schortgen F; Martin-Lefevre L; Verney C; Pons B; Boulet E; Boyer A; Chevrel G; Lerolle N; Carpentier D; de Prost N; Lautrette A; Bretagnol A; Mayaux J; Nseir S; Megarbane B; Thirion M; Forel JM; Maizel J; Yonis H; Markowicz P; Thiery G; Tubach F; Ricard JD; Dreyfuss D
Am J Respir Crit Care Med; 2018 Jul; 198(1):58-66. PubMed ID: 29351007
[TBL] [Abstract][Full Text] [Related]
35. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
[TBL] [Abstract][Full Text] [Related]
36. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury.
Liu KD; Glidden DV; Eisner MD; Parsons PE; Ware LB; Wheeler A; Korpak A; Thompson BT; Chertow GM; Matthay MA;
Crit Care Med; 2007 Dec; 35(12):2755-61. PubMed ID: 18074478
[TBL] [Abstract][Full Text] [Related]
37. Circulating microparticle levels are reduced in patients with ARDS.
Shaver CM; Woods J; Clune JK; Grove BS; Wickersham NE; McNeil JB; Shemancik G; Ware LB; Bastarache JA
Crit Care; 2017 May; 21(1):120. PubMed ID: 28545548
[TBL] [Abstract][Full Text] [Related]
38. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).
Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462
[TBL] [Abstract][Full Text] [Related]
39. Decreased microRNA 103 and microRNA 107 predict increased risks of acute respiratory distress syndrome and 28-day mortality in sepsis patients.
Wang Q; Feng Q; Zhang Y; Zhou S; Chen H
Medicine (Baltimore); 2020 Jun; 99(25):e20729. PubMed ID: 32569211
[TBL] [Abstract][Full Text] [Related]
40. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis.
Zhai R; Sheu CC; Su L; Gong MN; Tejera P; Chen F; Wang Z; Convery MP; Thompson BT; Christiani DC
Thorax; 2009 Sep; 64(9):784-90. PubMed ID: 19482841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
